Top news of the week: 09.11.2023.
Reviewing ZIVO Bioscience (NASDAQ:ZIVO) & Krystal Biotech (NASDAQ:KRYS)
ZIVO Bioscience (NASDAQ:ZIVO – Get Free Report) and Krystal Biotech (NASDAQ:KRYS – Get Free Report) are both medical companies, but which is the superior business? We will compare the two ...
Cowen AND Company LLC Invests $346,000 in RedHill Biopharma Ltd. (NASDAQ:RDHL)
Cowen AND Company LLC bought a new position in RedHill Biopharma Ltd. (NASDAQ:RDHL – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the ...
Krystal Biotech (NASDAQ:KRYS) Shares Gap Down to $122.15
Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $122.15, but opened at $112.00. Krystal Biotech ...
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Parallel Advisors LLC
Parallel Advisors LLC grew its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 0.9% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 40,902 shares of the ...
Modera Wealth Management LLC Acquires Shares of 21,853 SPDR S&P Biotech ETF (NYSEARCA:XBI)
Modera Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the 2nd quarter, according to the company in its most recent filing with ...
HBK Sorce Advisory LLC Sells 4,169 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)
HBK Sorce Advisory LLC decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 50.3% during the 2nd quarter, according to the company in its most recent filing with ...
Citizens Financial Group Inc. RI Invests $262,000 in SPDR S&P Biotech ETF (NYSEARCA:XBI)
Citizens Financial Group Inc. RI purchased a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the second quarter, according to its most recent disclosure with the SEC. ...
Xeris Biopharma (XERS) Scheduled to Post Earnings on Thursday
Xeris Biopharma (NASDAQ:XERS – Get Free Report) is set to release its earnings data before the market opens on Thursday, November 9th. Analysts expect Xeris Biopharma to post earnings of ...